微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 57.6% | 12.26% | 7.79% | 63/157 | 50.55% | 海创药业 | 99.82% | 行业排名> |
| 2025-12-31 | 53.44% | 20.71% | 2.6% | 68/157 | 50.61% | 海创药业 | 98.62% | 行业排名> |
| 2025-09-30 | 52.08% | 32.63% | -4.78% | 70/157 | -2.2% | 海创药业 | 99.57% | 行业排名> |
| 2025-06-30 | 54.7% | 33.82% | 6.6% | 65/157 | 14.83% | 海创药业 | 99.52% | 行业排名> |
| 2025-03-31 | 51.31% | 23.69% | 15.9% | 65/157 | 31.96% | 艾力斯 | 96.74% | 行业排名> |
| 2024-12-31 | 44.27% | -6.31% | 12.73% | 91/157 | 51.88% | 首药控股 | 98.96% | 行业排名> |
| 2024-09-30 | 39.27% | -21.23% | -3.93% | 101/157 | 22.51% | 迪哲医药 | 97.73% | 行业排名> |
| 2024-06-30 | 40.87% | -22.39% | -1.46% | 94/157 | 33.12% | 百利天恒 | 97.99% | 行业排名> |
| 2024-03-31 | 41.48% | -23.28% | -12.21% | 91/157 | 51.76% | 百利天恒 | 98.92% | 行业排名> |
| 2023-12-31 | 47.25% | 15.43% | -5.22% | 84/157 | 51.61% | 迈威生物 | 98.93% | 行业排名> |
| 2023-09-30 | 49.86% | 2% | -5.34% | 77/157 | 32.47% | 迈威生物 | 99.59% | 行业排名> |
| 2023-06-30 | 52.67% | 29.42% | -2.59% | 71/157 | 38.42% | 迈威生物 | 99.8% | 行业排名> |
| 2023-03-31 | 54.07% | 2% | 32.08% | 69/157 | 52.97% | 迈威生物 | 99.46% | 行业排名> |
| 2022-12-31 | 40.94% | -2.77% | 0.59% | 100/157 | 53.83% | 迈威生物 | 99.75% | 行业排名> |
| 2022-06-30 | 40.7% | -8.17% | -3.34% | 95/157 | 20.99% | 迈威生物 | 99.67% | 行业排名> |
| 2021-12-31 | 42.1% | -15.89% | -5% | 94/157 | 55.2% | 迈威生物 | 99.44% | 行业排名> |
| 2021-06-30 | 44.32% | -2.23% | -11.47% | 84/157 | 47.23% | 迈威生物 | 98.57% | 行业排名> |
| 2020-12-31 | 50.06% | 10.02% | 10.02% | 79/157 | -148.64% | 首药控股 | 99.93% | 行业排名> |
| 2019-12-31 | 45.5% | 23.4% | 0.38% | 87/157 | -1242.15% | 艾力斯 | 99.41% | 行业排名> |
| 2019-06-30 | 45.33% | 43.09% | 22.93% | 69/157 | 55.21% | 艾力斯 | 98.7% | 行业排名> |
| 2018-12-31 | 36.87% | 2% | 16.39% | 100/157 | -211.97% | 艾力斯 | 99.4% | 行业排名> |
| 2018-06-30 | 31.68% | 2% | 2% | 86/157 | 53.53% | 首药控股 | 99.94% | 行业排名> |